Day One Biopharmaceuticals, Inc. DAWN
Set alert
21.53 USD 0.00 0.00%
As of Apr 24, 9:30 AM ET
21.53 Day range 21.53
6.90 52-week range 21.53
- YTD
- +131.01%
- 1 year
- +172.53%
- Open
- 21.53
- Prev close
- 21.53
- Mkt cap
- 2.22B
- Vol
- 0
- Avg vol
- 1.52M
- EPS
- -1.03
- P/E
- -31.20
- Div yield
- 0.00%
More statistics
- Low
- 21.53
- High
- 21.53
- Beta
- -1.75
- Inst. own
- 83.49%
- Dividend
- 0.00
Financial health
Altman Z-Score
18.80 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -9.0×
FY 2019 5y median -10.7× FY 2025
P/S 6.1×
FY 2019 5y median 0.0× FY 2025
P/B 2.2×
FY 2019 5y median 3.4× FY 2025
P/FCF -9.3×
FY 2019 5y median -12.8× FY 2025
EV/EBITDA -7.3×
FY 2019 5y median -9.3× FY 2025
EV/Sales 4.9×
FY 2019 5y median 0.0× FY 2025
FCF Yield -10.8%
FY 2019 5y median -7.8% FY 2025
Profitability
Gross Margin 89.1%
FY 2019 5y median 0.0% FY 2025
Operating Margin -80.8%
FY 2019 5y median 0.0% FY 2025
Net Margin -67.8%
FY 2019 5y median 0.0% FY 2025
ROE -24.3%
FY 2019 5y median -25.1% FY 2025
ROIC -28.0%
FY 2019 5y median -42.7% FY 2025
ROA -21.1%
FY 2019 5y median -24.4% FY 2025
Growth (YoY)
Revenue 20.6%
FY 2019 FY 2025
Operating Income 41.2%
FY 2019 FY 2025
EPS (diluted) -2.0%
FY 2019 FY 2025
Free Cash Flow -29.6%
FY 2019 FY 2025
Financial Health
Current Ratio 8.0×
FY 2019 5y median 12.7× FY 2025
Quick Ratio 7.9×
FY 2019 5y median 12.7× FY 2025
Debt / Equity 0.0×
FY 2019 5y median 0.0× FY 2025
Net Debt / EBITDA 1.8×
FY 2019 5y median 1.4× FY 2025
Interest Coverage 0.0×
FY 2019 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31